TY - JOUR
T1 - Zero-covid advocacy during the COVID-19 pandemic
T2 - a case study of views on Twitter/X
AU - Kepp, Kasper P.
AU - Bardosh, Kevin
AU - De Bie, Tijl
AU - Emilsson, Louise
AU - Greaves, Justin
AU - Lallukka, Tea
AU - Muka, Taulant
AU - Rangel, J. Christian
AU - Sandström, Niclas
AU - Schippers, Michaéla C.
AU - Schmidt-Chanasit, Jonas
AU - Vaillancourt, Tracy
N1 - Publisher Copyright:
© The Author(s) under exclusive licence to Monash University 2024.
PY - 2024/9/3
Y1 - 2024/9/3
N2 - During the COVID-19 pandemic, many advocacy groups and individuals criticized governments on social media for doing either too much or too little to mitigate the pandemic. In this article, we review advocacy for COVID-19 elimination or “zero-covid” on the social media platform X (Twitter). We present a thematic analysis of tweets by 20 influential co-signatories of the World Health Network letter on ten themes, covering six topics of science and mitigation (zero-covid, epidemiological data on variants, long-term post-acute sequelae (Long COVID), vaccines, schools and children, views on monkeypox/Mpox) and four advocacy methods (personal advice and promoting remedies, use of anecdotes, criticism of other scientists, and of authorities). The advocacy, although timely and informative, often appealed to emotions and values using anecdotes and strong criticism of authorities and other scientists. Many tweets received hundreds or thousands of likes. Risks were emphasized about children’s vulnerability, Long COVID, variant severity, and Mpox, and via comparisons with human immunodeficiency viruses (HIV). Far-reaching policies and promotion of remedies were advocated without systematic evidence review, or sometimes, core field expertise. We identified potential conflicts of interest connected to private companies. Our study documents a need for public health debates to be less polarizing and judgmental, and more factual. In order to protect public trust in science during a crisis, we suggest the development of mechanisms to ensure ethical guidelines for engagement in “science-based” advocacy, and consideration of cost–benefit analysis of recommendations for public health decision-making.
AB - During the COVID-19 pandemic, many advocacy groups and individuals criticized governments on social media for doing either too much or too little to mitigate the pandemic. In this article, we review advocacy for COVID-19 elimination or “zero-covid” on the social media platform X (Twitter). We present a thematic analysis of tweets by 20 influential co-signatories of the World Health Network letter on ten themes, covering six topics of science and mitigation (zero-covid, epidemiological data on variants, long-term post-acute sequelae (Long COVID), vaccines, schools and children, views on monkeypox/Mpox) and four advocacy methods (personal advice and promoting remedies, use of anecdotes, criticism of other scientists, and of authorities). The advocacy, although timely and informative, often appealed to emotions and values using anecdotes and strong criticism of authorities and other scientists. Many tweets received hundreds or thousands of likes. Risks were emphasized about children’s vulnerability, Long COVID, variant severity, and Mpox, and via comparisons with human immunodeficiency viruses (HIV). Far-reaching policies and promotion of remedies were advocated without systematic evidence review, or sometimes, core field expertise. We identified potential conflicts of interest connected to private companies. Our study documents a need for public health debates to be less polarizing and judgmental, and more factual. In order to protect public trust in science during a crisis, we suggest the development of mechanisms to ensure ethical guidelines for engagement in “science-based” advocacy, and consideration of cost–benefit analysis of recommendations for public health decision-making.
UR - http://www.scopus.com/inward/record.url?scp=85203012462&partnerID=8YFLogxK
U2 - 10.1007/s40592-024-00205-2
DO - 10.1007/s40592-024-00205-2
M3 - Article
C2 - 39225854
AN - SCOPUS:85203012462
SN - 1321-2753
VL - 42
SP - 169
EP - 199
JO - Monash bioethics review
JF - Monash bioethics review
IS - 2
ER -